November 12th, 2024
Sports equipment designed for women, by women
‘Shrink it and pink it’ is not the answer. Harvard Grid hosts a panel on the lack of female representation in athletic product design.
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
October 28th, 2024
Four Harvard research teams receive translational funding to advance climate change tech
With funding and support from the Climate and Sustainability Translational Fund, researchers will pursue green jet fuel, cleaner chemicals, sustainable packaging, and carbon storage.
October 2nd, 2024
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
Attivare Therapeutics, a Harvard startup out of the Wyss Institute, has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS), Dana-Farber Cancer Institute, and Massachusetts General Hospital. This technology creates an in vivo training ground for the immune system to fight cancer more effectively and prevent infection.
September 19th, 2024
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy
GC Therapeutics (GCTx), a Harvard startup, announced its launch to scale and its technology TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies in multiple therapeutic areas.
September 12th, 2024
Breakthrough technique may help speed understanding, treatment of MD, ALS
Harvard researchers have pioneered a groundbreaking method for generating large numbers of adult skeletal-muscle satellite cells, also known as muscle stem cells, in vitro.
